Compare WASH & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WASH | ARCT |
|---|---|---|
| Founded | 1800 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 585.9M | 194.1M |
| IPO Year | N/A | N/A |
| Metric | WASH | ARCT |
|---|---|---|
| Price | $30.80 | $7.14 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 11 |
| Target Price | $30.25 | ★ $38.67 |
| AVG Volume (30 Days) | 99.4K | ★ 846.7K |
| Earning Date | 01-28-2026 | 11-10-2025 |
| Dividend Yield | ★ 7.28% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $117,341,000.00 | $97,601,000.00 |
| Revenue This Year | $57.78 | N/A |
| Revenue Next Year | $8.69 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $24.95 | $5.85 |
| 52 Week High | $35.27 | $24.17 |
| Indicator | WASH | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 71.85 | 40.13 |
| Support Level | $30.45 | $7.04 |
| Resistance Level | $31.03 | $7.76 |
| Average True Range (ATR) | 0.52 | 0.39 |
| MACD | 0.21 | 0.37 |
| Stochastic Oscillator | 93.63 | 63.37 |
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.